Zizzari, Ilaria Grazia <br/><br/>
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway.  [electronic resource] 

 -  Cancer immunology research  06 2018 
 - 711-722 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-17-0594  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>B7-H1 Antigen--genetics<br/>Biomarkers<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Line, Tumor<br/>Cytokines--metabolism<br/>Dendritic Cells--drug effects<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Immunophenotyping<br/>Indazoles<br/>Kidney Neoplasms--drug therapy<br/>Phagocytosis--immunology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidines--pharmacology<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology<br/>T-Lymphocytes--drug effects<br/>beta Catenin--metabolism